-
10%
Investigated for its ability to inhibit NNMT, linked to fat cell size and energy expenditure. Research models show enhanced NAD+ levels and metabolic efficiency. BioBoost Labs does not provide medical advice or dosing guidance of any kind. -
10%
A fragment of human growth hormone (176–191) studied for its effect on fat metabolism through lipolysis activation and lipogenesis inhibition. Shown to reduce adipose tissue in preclinical and clinical models. -
10%
Combination studied for enhanced regenerative effects, particularly in muscle, tendon, and ligament recovery models. Shows synergistic influence on cellular migration and healing. -
10%
A synthetic peptide derived from a gastric protein, widely researched for tissue repair, angiogenesis support, and inflammatory modulation. Used in musculoskeletal, vascular, and gut-related studies. -
10%
An amylin receptor agonist under research for its effects on appetite regulation and body weight management in combination with GLP-1 receptor agonists. -
10%
Dual peptide blend studied for stimulating growth hormone release without elevating cortisol or prolactin. Evaluated for metabolic and recovery-related outcomes. -
10%
A synthetic tetrapeptide derived from the pineal gland peptide epithalamin. Research focuses on its telomerase activation and potential cellular aging regulation. -
10%
Investigated for its senolytic properties, this peptide disrupts FOXO4–p53 interactions to promote apoptosis in senescent cells, targeting aging and tissue regeneration pathways. -
10%
A copper-binding tripeptide explored for its role in wound healing, collagen synthesis, and hair growth. Demonstrates antioxidant and tissue-repair properties in cellular studies. -
10%
Endogenous antioxidant peptide evaluated for detoxification support, oxidative stress reduction, and immune balance. Promotes redox cycling and cell protection.
You must be logged in to post a comment.